Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anthrax Vaccine Stockpile For Civilians Created From Half Of BioPort Output

Executive Summary

A joint DoD/HHS effort to reinstate the military Anthrax Vaccination Immunization Program will set aside roughly half of produced vaccine to increase emergency civilian stockpiles

You may also be interested in...



DoD Vaccine Report Proposes Interdepartmental Group To Work With Industry

The Department of Defense is recommending the development of an interdepartmental "executive council" that would advise the federal government on vaccine planning and serve as the primary point of contact with vaccine manufacturers on procurement

DoD Vaccine Report Proposes Interdepartmental Group To Work With Industry

The Department of Defense is recommending the development of an interdepartmental "executive council" that would advise the federal government on vaccine planning and serve as the primary point of contact with vaccine manufacturers on procurement

Anthrax Vaccine Research, Stockpile Supported In Bush Budget

The Bush Administration's FY 2003 budget request includes funding for a feasibility study on creating a recombinant anthrax vaccine stockpile

UsernamePublicRestriction

Register

PS040103

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel